When.com Web Search

  1. Ad

    related to: edwards lifesciences acquisition
    • M&A Deal Data

      Get insight into valuable and up to

      date M&A deals in any industry.

    • Morningstar Research

      Morningstar is a leading provider

      of independent investment research.

Search results

  1. Results From The WOW.Com Content Network
  2. Edwards Lifesciences Is Poised For Solid Growth In 2025 ...

    www.aol.com/edwards-lifesciences-poised-solid...

    Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise ...

  3. Edwards Lifesciences - Wikipedia

    en.wikipedia.org/wiki/Edwards_Lifesciences

    Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]

  4. Edwards Lifesciences Outlines Vision For Growth At Investor ...

    www.aol.com/edwards-lifesciences-outlines-vision...

    On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies.

  5. Edwards Lifesciences shares fall as slow heart-valve growth ...

    www.aol.com/news/edwards-lifesciences-shares...

    Edwards lifted its 2023 sales forecast to between $5.9 billion and $6.1 billion, from $5.6 billion to $6.0 billion estimated earlier. The new mid-point is slightly higher than analysts' estimates ...

  6. Medtronic - Wikipedia

    en.wikipedia.org/wiki/Medtronic

    In June, the company announced its acquisition of HeartWare International Inc. for $1.1 billion. [15] In December 2017, Medtronic acquired Crospon in €38 million ($45 million). [16] In September 2018, the company acquired Mazor Robotics for $1.64 billion ($58.50 per American Depository Share or $29.25 per ordinary share. [17]

  7. Hologic - Wikipedia

    en.wikipedia.org/wiki/Hologic

    The acquisition completed in June 2021. [19] In March 2022, Hologic became the title sponsor of the WTA Tour in women's professional tennis. As part of the sponsorship, the company was also named the "official health partner" of the Women's Tennis Association. [20]

  8. Exclusive-Edwards Lifesciences cooperating with EU ... - AOL

    www.aol.com/exclusive-edwards-lifesciences...

    Edwards Lifesciences' shares had dipped 2.5% in pre-market trade after Reuters published a story citing two people with direct knowledge of the EU raid. The European Commission on Sept. 19 said it ...

  9. EQT AB - Wikipedia

    en.wikipedia.org/wiki/EQT_AB

    EQT AB is a Swedish global investment organization founded in 1994. [2] Its funds invest in private equity, infrastructure, real estate, growth equity, and venture capital in Europe, North America, and Asia Pacific.

  1. Ad

    related to: edwards lifesciences acquisition